ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas Manley, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
144 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Adelaide Hospital
Adelaide, Australia
- Moorabbin Hospital
Bentleigh East, Australia
- Icon Cancer Care Chermside
Chermside, Australia
- Icon Cancer Care South Brisbane
Chermside, Australia
- Icon Cancer Care Southport
Chermside, Australia
- Icon Cancer Care Wesley
Chermside, Australia
- Monash Medical Centre
Clayton, Australia
- Concord Repatriation General Hospital
Concord, Australia
- St. Vincent'S Hospital Sydney
Darlinghurst, Australia
- St Vincent'S Public Hospital Sydney - Fitzroy
Fitzroy, Australia
- Western Hospital
Footscray, Australia
- Austin Health
Heidelberg, Australia
- Calvary Mater Newcastle
Waratah, Australia
- Jewish General Hospital
Montreal, Canada
- Mcgill University Department of Oncology / Mcgill University Health Centre
Montreal, Canada
- Sunnybrook Health Sciences Centre
Toronto, Canada
- British Columbia Cancer Agency - Vancouver Centre
Vancouver, Canada
- Fakultni Nemocnice Brno
Brno, Czechia
- Fakultni Nemocnice Hradec Kralove-Oddeleni Klinicke Hematologie
Hradec Králové, Czechia
- Fakultni Nemocnice Ostrava
Ostrava - Poruba, Czechia
- Fakultni Nemocnice Kralovske Vinohrady
Prague, Czechia
- Vseobecna Fakultni Nemocnice V Praze
Prague, Czechia
- Aarhus University Hospital
Aarhus C, Denmark
- Rigs Hospiltalet
Copenhagen, Denmark
- Odense University Hospital
Odense C, Denmark
- Hôpital Henri Mondor
Créteil, France
- Chd Vendée, Site de la Roche-Sur-Yon, Les Oudairies
La Roche-sur-Yon, France
- Centre Hospitalier Universitaire de Grenoble
La Tronche, France
- Clinique Victor Hugo
Le Mans, France
- Chru de Lille
Lille, France
- Centre Hospitalier Universitaire (chu) de Limoges - Hopital Dupuytren
Limoges, France
- Centre Hospitalier Universitaire Nantes-Hotel Dieu
Nantes, France
- Groupe Hospitalier Pitié-Salpétrière
Paris, France
- Hopital Saint-Louis / Service D'Hematologie
Paris, France
- Groupe Hospitalier Du Haut Leveque
Pessac, France
- Centre Hospitalier Lyon Sud
Pierre-Bénite, France
- Centre Hospitalier Universitaire de Poitiers
Poitiers, France
- Centre Hospitalier Universitaire de Rennes, Hopital Pontchaillou
Rennes, France
- Centre Henri Becquerel / Centre Regional de Lutte Contre Le Cancer
Rouen, France
- Charite Campus Benjamin Franklin
Berlin, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2013
- Primary completion
- 15 Aug 2018
- Completion
- 2 Oct 2020
- Last update posted
- 30 Nov 2021
- Registered enrollment
- 452
- Registry id
- NCT01777152
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.